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ABSTRACT
Objective: The objective of the study was to investigate the correlation of gender and serum leptin level with analgesic modulation of tramadol in 
Wistar rats.
Methods: A total of 48 Wistar rats (body weight 100–150 g), 24 each male and female Wistar rats were randomly divided into two groups (n=6/group) 
(Group I - Control- 0.9% NaCl; 1 ml/kg/day i.p. and Group II - Tramadol 10 mg/kg/day i.p.) for each nociception model - plantar test and acetic acid 
induced writhing test. The treatment duration was of 5 days. Paw withdrawal latency (PWL) was assessed using plantar test and writhing movements 
were observed following administration of 0.8% acetic acid; 10 ml/kg i.p.
Results: PWL was significantly decreased (p<0.001) and both number of writhing movements and serum leptin concentrations were significantly 
increased (p<0.001) in female control group compared to male control group. In tramadol treated female rats, PWL was significantly decreased 
(p=0.005) and both number of writhing movements and serum leptin concentrations were significantly increased (p<0.001) in comparison with 
the tramadol treated male rats. PWL was negatively correlated with serum leptin concentration (Pearson correlation coefficient= −0.826, two-tailed 
significance= 0.000), and writhing movements were positively correlated with serum leptin concentration (Pearson correlation coefficient= 0.505, 
two-tailed significance= 0.012).
Conclusions: The present study revealed that female rats have more serum leptin concentration than male rats which could be one of the possible 
reasons for having more pain sensitivity to noxious stimuli in female rats compared to male rats. Tramadol treatment at the dose of 10 mg/kg for 
5 days has decreased serum leptin level in rats which might be one of the additional mechanisms of tramadol to reduce pain.
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INTRODUCTION
In pathological term, pain may be defined as “sensory consequence of 
neuronal activity triggered by noxious stimuli, inflammation or damage 
to specific nociceptive pathways in the nervous system [1]. It is quite 
evident for any clinician who treats patients in pain knows that one size 
does not fit all. There is no one standard dose or specific medication 
that will provide adequate analgesia to all patients. The optimal current 
approach is to titrate analgesics to produce optimal therapeutic benefit.
Gender-related influences on the experience of pain have been received 
considerable empirical attention in recent years [2-7]. It is generally 
accepted that males and females respond differently to painful 
conditions. Women report more pain than men and are at greater 
risk for developing many forms of chronic pain [2]. Sex differences 
are not limited to pain perception but may extend to the response to 
analgesics. There is little agreement about a differential response of 
men and women to opioid analgesics. In animals, male rats exhibit 
greater analgesia than female rats to equal doses of opioids [8,9]. In 
case of morphine, a gender difference is reported in its anti-nociceptive 
effect both in animals and human in spite of no gender-linked difference 
in serum levels of morphine [10-12]. In humans, sex differences in 
response to opioids have been described, but the findings are difficult 
to consolidate.
Leptin is secreted by adipocytes in proportion to the amount of body 
fat and exerts a potent inhibitory action on food intake. In humans, 
serum leptin concentrations correlate positively with percent body fat. 
Several studies have positively correlated the experience of pain with 
an increase in body mass index (BMI) [13,14]. It is not known whether 
obesity causes chronic pain, chronic pain causes obesity, or some other 
factor causes both concurrently. Obesity is hypothesized to lead to pain 
because of excess mechanical stresses and its pro-inflammatory state.
Differences in pain thresholds may have implications for pain management, 
as they may account in part for the variability in analgesic requirements 
between individuals. There is a need for further studies to investigate 
the correlation of gender and leptin with pain threshold and analgesic 
effect of opioids. Tramadol is a synthetic, centrally acting analgesic agent 
with two distinct, synergistic mechanisms of action, acting as both a 
weak opioid agonist and an inhibitor of monoamine neurotransmitter 
reuptake [15]. Earlier, we had reported the analgesic modulation of some 
analgesics in male and female Wistar rats [16]. Consequently, the aim of 
the present study was to investigate the correlation of gender and leptin 
with analgesic effect of tramadol in Wistar rats.
METHODS
Drugs and reagents
Active pharmaceutical ingredient of tramadol and rat leptin ELISA kit 
was procured from Sigma-Aldrich, Bengaluru, India. Acetic acid and 
other chemicals were purchased from Merck Life Sciences Pvt., Ltd., 
Mumbai, India. Normal saline (0.9% sodium chloride) was purchased 
from the pharmacy of Kasturba Hospital, Manipal, Karnataka, India.
Animals
A total of 48 (24 male and 24 female) Wistar rats weighing 100–150 g 
were housed in separate polypropylene cages, maintained under 
standard conditions with temperature (22–24°C), 12-h light/12-h 
dark cycle and relative air humidity 40–60%. The animals were 
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acclimatized to the laboratory conditions for 1 week before the start of 
the experiment. The animals were provided with a normal pellet diet 
(Amrit Feeds Ltd., Pune, India) and water ad libitum. The experimental 
protocol was approved by the Institutional Animal Ethics Committee 
(IAEC/KMC/41/2014) and experiments were conducted according 
to the ethical norms approved by the Ministry of Social Justice and 
Empowerment, Government of India, and Committee for the Purpose of 
Control and Supervision of Experiments on Animals guidelines.
Experimental design
A total of 48 Wistar rats (body weight 100–150 g), 24 each male and 
female Wistar rats were randomly divided into two groups (n=6/group) 
(Group I - Control- 0.9% NaCl; 1 ml/kg/day i.p. and Group II - Tramadol 
10 mg/kg/day i.p.) for each nociception model - plantar test and acetic 
acid induced writhing test (Fig. 1). The treatment duration was of 5 days. 
On the last day of treatment (i.e. on the 5th day); 15 min after tramadol/
normal saline treatment, animals were tested for the respective pain 
model. Paw withdrawal latency (PWL) was assessed using plantar test, 
and writhing movements were observed following administration of 
0.8% acetic acid; 10 ml/kg i.p [16-18].
Nociception models
Plantar test (Hargreaves’ method)
Thermal pain threshold to radiant heat (IR- 90) was quantified using the 
paw withdrawal test (Fig. 2). Rats were placed in a perspex enclosure, 
without restraint and a movable infrared radiant heat source placed 
directly under the plantar surface of the hind paw (Ugo Basile, Como, 
Italy). The PWL to radiant heat was defined as the time from onset 
of the radiant heat to the withdrawal of the rat hind paw. The cutoff 
time for PWL was 30 s. Testing was alternated between hind paws and 
carried out at 3 min intervals. The average of three estimations was 
taken to yield mean PWL. Before any testing was carried out, rats could 
adjust to their environments for at least 10 min.
Acetic acid-induced writhing test
Writhing movement was induced by administering an intraperitoneal 
injection of 0.8% acetic acid (10 ml/kg), 15 min after the tramadol/
normal saline administration. After 10 min of acetic acid administration, 
the number of writhing movements such as abdominal constriction/
elongation of body/arching of back/hind limb extension/forelimb 
extension/trunk twisting (Fig. 3) was cumulatively counted over 
20 min further for nociceptive evaluation [16-18].
Collection of blood sample
Following anesthesia with ketamine 60 mg/kg and xylazine 5 mg/kg; 
i.p., blood was withdrawn from retro-orbital plexus of rats through 
capillary tube [19]. Following collection of blood in micro-centrifuge 
tubes and its clot formation, serum was obtained by centrifugation of 
blood at 3,000 rpm for 20 min at 4°C using a refrigerated centrifuge 
(MIKRO 22R, Andreas Hettich GmbH & Co. KG, Germany). The 
Fig. 1: Experimental design
Fig. 2: Hargreaves apparatus for plantar test
Fig. 3: (a-d) Acetic acid-induced writhing movements
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resulting supernatant (serum) was stored at −80°C for estimation 
of leptin concentration. All the surviving experimental animals were 
rehabilitated after the completion of the study.
Estimation of serum leptin concentration
As per the assay protocol given along with rat leptin ELISA kit, all 
reagents and samples were kept at room temperature (22–25°C) before 
use. 100 µl of each standard and sample was added to appropriate 
wells. Wells were covered and incubated for 2.5 h at room temperature 
or overnight at 4°C with gentle shaking. The solution was discarded 
and washed 4 times with 1x wash solution. Washing by filling each well 
with wash buffer (300 µl) was done using a multichannel pipette. After 
the last wash, any remaining wash buffer was removed by aspirating 
or decanting. The plate was inverted and blotted against clean paper 
towels. 100 µl of 1x prepared Biotinylated Detection Antibody was 
added to each well followed by incubation for 1 h at room temperature 
with gentle shaking. The solution was discarded. Washing was repeated 
4 times. 100 µl of prepared HRP-streptavidin solution was added 
to each well followed by incubation for 45 min at room temperature 
with gentle shaking. Solution was discarded and washed again 4 times. 
100 µl of ELISA Colorimetric TMB Reagent was added to each well 
followed by incubation for 30 min at room temperature in the dark 
with gentle shaking. 50 µl of stop solution was added to each well and 
absorbance was read at 420 nm immediately. The mean absorbance for 
each set of duplicate standards, controls, and samples was entered in 
the Microsoft Excel sheet, and average zero standard optical density 
was subtracted from each mean absorbance. A standard curve with 
standard concentration on the X-axis and absorbance on the Y-axis was 
plotted and following that leptin concentration (pg/ml) was calculated.
Statistical analysis
Using Statistical Package for the Social Sciences version 16.0, data 
were expressed as mean±standard deviation and analyzed by one-way 
analysis of variance followed by post hoc Tukey test. The correlation of 
pain and serum leptin concentration was done using bivariate analysis 
followed by Pearson correlation coefficient and two-tailed significance. 
A level for p≤0·05 was considered as statistically significant.
RESULTS
PWL was significantly decreased (p<0.001) and both number of 
writhing movements and serum leptin concentrations were significantly 
increased (p<0.001) in female control group compared to male control 
group. Tramadol treated both male and female rats had significantly 
increased PWL (p<0.001) and decreased both number of writhing 
movements and serum leptin concentration (p<0.001) in comparison 
with both male and female control groups, respectively. In tramadol 
treated female rats, PWL was significantly decreased (p=0.005) and 
both number of writhing movements and serum leptin concentration 
were significantly increased (p<0.001) in comparison with the tramadol 
treated male rats (Fig. 4). PWL was negatively correlated with serum 
leptin concentration (Pearson correlation coefficient= −0.826 and 
two-tailed significance= 0.000), which means PWL was significantly 
decreasing (means more pain) with increased levels of serum leptin 
(Fig. 5). A number of writhing movements were positively correlated 
with serum leptin concentration (Pearson correlation coefficient=0.505 
and two-tailed significance=0.012), which means writhing movements 
were significantly increasing (means more pain) with increased levels 
of serum leptin levels (Fig. 6).
DISCUSSION
The present study has demonstrated the correlation of gender and 
leptin with analgesic modulation of tramadol in Wistar rats. We found 
the significant increase in serum leptin levels and decrease in pain 
threshold (more pain sensitivity to noxious stimuli) in female rats than 
male rats. The significant increase in serum leptin concentration in 
female rats in the present study is in agreement with Mendonca et al. 
who found a positive and statistically significant correlation between 
estrogen and leptin independent of body mass index [20]. According to 
Shimizu et al. and Messinis et al., estrogen can be an important regulator 
of leptin production in women [21,22]. The gender difference in serum 
leptin concentration is well established and in vitro results suggest that 
gonadal hormones, such as testosterone, may be important regulators 
of leptin secretion [23-25]. In both humans and rodents, males have 
lower plasma leptin concentrations than their female counterparts at 
any level of adiposity [26,27]. A strong inverse association between 
serum levels of leptin and testosterone was recently reported in 
untreated and testosterone-treated hypogonadal men [28,29]. In the 
present study also, we found significantly lower levels of leptin in male 
rats compared to female rats which might be due to downregulation of 
serum leptin by testosterone. The mechanism underlying this effect of 
testosterone remains to be elucidated.
Fig. 4: Comparison of paw withdrawal latency (in seconds), number of writhing movements, and serum leptin concentration (pg/ml) 
among experimental groups
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In the present study, tramadol treatment at the dose of 10 mg/kg 
for 5 days has decreased serum leptin level in both male and female 
rats. Some of the studies also suggest the decrease in serum leptin 
concentration with tramadol (opioid agonist) treatment at the dose 
of 0.5 mg/kg/day orally when administered for 4 weeks [30,31]. If we 
calculate the total amount of tramadol for 5 days in our study which 
comes to 50 mg/kg and in the above-mentioned studies it is 14 mg/kg 
in the total 4 weeks duration then the dose and duration of tramadol 
treatment in our study is even more than these studies where serum 
leptin level was decreased. Decrease in serum leptin level by tramadol 
at the dose of 10 mg/kg for 5 days treatment duration could be one of 
the additional mechanisms of tramadol to reduce pain.
There was a significant positive correlation found between pain and 
serum leptin levels in our study. One of the effects of increased serum 
leptin levels may be greater sensitivity to pain. The relationship 
between leptin and pain may be modulated by other factors, with 
estrogen being one possibility [32]. In rat and mouse models, leptin 
has been shown to reduce the threshold for pain [33]. Leptin has also 
been shown to increase levels of interleukin-1, a cytokine known to 
cause hyperalgesia [34]. Recent studies have shown that leptin, an 
adipocytokine, played a significant role in nociceptive behavior induced 
by nerve injury in rats [35,36]. Maeda et al. suggests that peripheral 
effect of leptin on neuropathic pain is mediated via macrophage 
stimulation [36]. Following more leptin levels in female rats compared 
to males, these could be the possible reasons for more pain in female 
rats than male rats.
CONCLUSIONS
The present study revealed that female rats have more serum leptin 
concentration than male rats which could be one of the possible reasons 
for having more pain sensitivity to noxious stimuli in female rats 
compared to male rats. Further information regarding the link between 
leptin and pain may help drive novel treatments for pain. Tramadol 
treatment at the dose of 10 mg/kg for 5 days has decreased serum 
leptin level in rats which might be one of the additional mechanisms 
of tramadol to reduce pain. Additional research to elucidate the 
mechanisms driving sex hormones and leptin in pain responses is 
needed to foster future interventions to reduce these disparities in 
pain and analgesic modulation of tramadol. Gender and body mass 
index-specific tailoring of pain treatments may become a conceivable 
outcome in the foreseeable future.
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